பராமரிப்பு உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பராமரிப்பு உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பராமரிப்பு உலகளாவிய ஆண்டிமைக்ரோபியல் எதிர்ப்பு கண்டுபிடிப்பு நிதி Today - Breaking & Trending Today

SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic


SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic
on May 11 2021 6:00 AM
Test will detect infection of chlamydia and gonorrhoea and determine antimicrobial susceptibility to easy-to-access antibiotics within 60 minutes
SYDNEY (BUSINESS WIRE) #AntimicrobialStewardship SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, announced it has been awarded up to US $1.8 million from CARB-X, a global non-profit partnership dedicated to supporting research and development to address the rising threat of drug-resistant bacteria. SpeeDx represents the first Australian-based diagnostics company to receive CARB-X funding and a further $1.9 million will be available once the project reaches defined milestones. Funds will be used to develop a rapid test for the combined detection of ....

United States , New Zealand , United Kingdom , City Of , Debra Daglish , Jonathan Ohalloran , Colin Denver , Antimicrobialstewardship Speedx Pty , Madeline Odonoghue , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Us Department Of Health , Quantumdx Group , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , Biomedical Advanced Research , Human Services , Boston University , Development Authority , Germany Federal Ministry Of Education , Office Of The , Us National Institutes Of Health , Chief Executive , Assistant Secretary , Wellcome Trust ,

Baebies Awarded up to $11.6 Million from CARB-X for the Development of a Diagnostic Platform with Rapid Results for Sepsis


/ April 20, 2021 /
Baebies, a growth-stage company developing innovative products to enable early disease detection and comprehensive diagnosis, announced today that CARB-X has awarded the company up to $11.6 million in non-dilutive funding. This funding will support the development of a near-patient and rapid diagnostic platform for sepsis - specially focused on addressing the unique needs of neonatal and pediatric populations.
The CARB-X award consists of $3.9 million in initial funding with up to $7.7 million of milestone-based funding. CARB-X, a global non-profit partnership, provides funding and support for projects that target drug-resistant bacteria deemed Serious or Urgent on the U.S. Centers for Disease Control and Prevention (CDC) Antibiotic Resistant Threats list or Critical or High on the World Health Organization s Priority Bacterial Pathogens list. ....

North Carolina , United States , United Kingdom , Emily Mcloughlin , Vamsee Pamula , Richard West , Us Centers For Disease , Boston University School Of Law , National Institute Of Allergy , Melinda Gates Foundation , Baebies Inc , Us Department Of Health , United Kingdom Department Of Health , Care Global Antimicrobial Resistance Innovation Fund , World Health Organization Priority Bacterial Pathogens , Biomedical Advanced Research , Human Services , Boston University , Disruptive Technology Award , Development Authority , Germany Federal Ministry Of Education , United Kingdom Government Department Of Health , Office Of The , Us National Institutes Of Health , Disease Control , Antibiotic Resistant Threats ,